Form 4 for CNSP CNS Pharmaceuticals, Inc.
Accepted 2026-08-18 09:00:03 ET · period of report 2026-08-14 · accession 0001683168-26-006552 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 09:00 | 2026-08-14 | CNSP | Levin Rami | CEO, Pres | M - OptEx | $0.00 | -4,750 | 4,750 | -50% | $0 |
| D | 2026-08-18 09:00 | 2026-08-14 | CNSP | Levin Rami | CEO, Pres | M - OptEx | $0.00 | -4,750 | 14.2K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-14 | M | D | 4,750 | $0.00 | 4,750 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2026-08-14 | M | D | 4,750 | $0.00 | 14,250 | D | — · — to — | 4,750 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Company common stock. (F3) Issued in connection with the reporting person's employment with the Company. (F2) On January 1, 2026, the reporting person was granted 19,000 restricted stock units, vesting as follows: 25% on the six-month anniversary of the grant date, 25% on the twelve-month anniversary of the grant date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date. (F2) On January 1, 2026, the reporting person was granted 19,000 restricted stock units, vesting as follows: 25% on the six-month anniversary of the grant date, 25% on the twelve-month anniversary of the grant date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date. (F2) On January 1, 2026, the reporting person was granted 19,000 restricted stock units, vesting as follows: 25% on the six-month anniversary of the grant date, 25% on the twelve-month anniversary of the grant date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date. |